Trial intelligence / Profile preview

Comparison of Diuretic Strategies in Heart Failure (3T Trial)

NCT02606253Phase 4Completed

Sponsor
Vanderbilt University
Start
Feb 2016
Primary completion
Sep 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tolvaptan in heart failure (HF), sponsored by Vanderbilt University. Started Feb 2016; status: completed.

02

Drugs

tolvaptan
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT02606253.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02606253.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call